FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to urology, and can be used in treatment of urolythiasis. For this purpose irrigation of kidney cavity with lytholytic solution is performed. Lytholytic solution includes at least one complexon and ampicillin in amount 0.2-0.3 wt %. As complexon used is mixture in amount 3.4-3.9 wt %. Mixture contains disodium salt of ethylenediamintetraacetic acid 0.9-1.1 wt % and potassium citrate 2.5-2.8 wt %. Irrigation is performed at temperature 36.8-37.2°C, with constant rate of lytholytic solution supply, selected within 1-5 ml/min.
EFFECT: method ensures efficient lytholysis of oxalate calculi with simultaneous dissolution of urate and phosphate inclusions at lower concentrations of lytholytic solutions, which reduces kidney trauma and ensures prevention of complications associated with bacterial infection.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EXCISION OF RESIDUAL CONCREMENTS IN PATIENTS WHO SUSTAINED SURGICAL PROCEDURE | 2008 |
|
RU2376017C1 |
METHOD FOR LYTHOLYSIS OF URIC ACID CONCREMENTS, SALTS AND MIXED URATE-OXALATE CALCULI IN HUMAN URINARY SYSTEM | 2013 |
|
RU2559567C2 |
METHOD OF TREATMENT OF URATE UROLITHIASIS | 0 |
|
SU1090403A1 |
METHOD OF URATE UROLITHIASIS TREATMENT | 1997 |
|
RU2144390C1 |
AGENT FOR PROPHYLAXIS AND TREATMENT OF UROLITHIASIS DISEASE | 2002 |
|
RU2205655C1 |
AGENT FOR LITHOLYSIS OF URINARY CALCULUS AND METHOD FOR ITS PREPARING | 2003 |
|
RU2238735C1 |
METHOD FOR REMOTE MONITORING OF URINE PH IN PATIENTS WITH URATE UROLYTHIASIS | 2019 |
|
RU2716426C2 |
PREPARATION FLAVOSUCCINE FOR TREATING AND PREVENTING RENAL AND URINARY DISEASES | 2010 |
|
RU2456011C1 |
AGENT FOR PREVENTING AND TREATING UROLITHIASIS | 2015 |
|
RU2580282C1 |
METHOD OF TREATING CHRONIC CALCULOUS PROSTATITIS | 2013 |
|
RU2534853C1 |
Authors
Dates
2011-11-10—Published
2009-10-19—Filed